In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...

In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...

Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...

Multiple myeloma and amyloidosis begin the same way – in plasma cells, white blood cells that help your immune system. But multiple myeloma (MM) is a rare blood cancer while amyloidosis is a ...

Alnylam Pharmaceuticals, Inc. ALNY announced that the European Commission (EC) has approved a label expansion of its RNAi therapeutic Amvuttra.The EC has now approved Amvuttra for the treatment of ...

Amyloidosis occurs due to a buildup of amyloid proteins in the body. Along with treatment, complementary therapy can help with symptoms. Some examples include movements, such as yoga, sleep ...

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.

Amyloidosis occurs when the proteins in the body become sticky and begin to clump together, Sperry says. In the brain, there's a type of amyloidosis that people know as Alzheimer’s disease.

Wainua is an injectable medicine. Here’s how it treats hereditary transthyretin-mediated amyloidosis (hATTR).

Elsie soon learned the cause - cardiac amyloidosis. "We used to think of it more as a rare disease," says Dr. Carly Fabrizio of Temple Health. But Dr. Fabrizio says heart failure specialists like ...

Cardiac amyloidosis portends a poor prognosis, with a median survival less than 6 months without treatment. However, if it is recognized early, there are specific treatments available.